Accounts Payable - Diffusion Pharmaceuticals Inc (NASDAQ:CRVO) - Alpha Spread
D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 17.47 USD 10.57% Market Closed
Market Cap: 144.2m USD
Have any thoughts about
Diffusion Pharmaceuticals Inc?
Write Note

Diffusion Pharmaceuticals Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Diffusion Pharmaceuticals Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
D
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Accounts Payable
$662.5k
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
5%
Abbvie Inc
NYSE:ABBV
Accounts Payable
$29.3B
CAGR 3-Years
12%
CAGR 5-Years
21%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$537m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$2.3B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$327.9m
CAGR 3-Years
37%
CAGR 5-Years
34%
CAGR 10-Years
20%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$561.7m
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
28%

See Also

What is Diffusion Pharmaceuticals Inc's Accounts Payable?
Accounts Payable
662.5k USD

Based on the financial report for Jun 30, 2024, Diffusion Pharmaceuticals Inc's Accounts Payable amounts to 662.5k USD.

What is Diffusion Pharmaceuticals Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
5%

Over the last year, the Accounts Payable growth was -29%. The average annual Accounts Payable growth rates for Diffusion Pharmaceuticals Inc have been -4% over the past three years , 6% over the past five years , and 5% over the past ten years .

Back to Top